Cyanocobalamin is the most widely available synthetic form, is shelf-stable, and is FDA-approved for treating B12 deficiency
The 45.3% figure nearly half of all patients losing 30% of their body weight is unprecedented in obesity pharmacotherapy
Excessive LA intake can contribute to obesity-related conditions, such as fat accumulation, inflammation, and fatty liver disease 80,81,82
Our analysis of individual outcomes revealed substantial reductions in all-cause mortality, MAKE, and MALO with combination therapy, yielding several significant clinical implications
Over time, this can create a cycle of escalating doses, worsening sensitivity, and declining function without meaningful healing (33,35,36)
However, safe and effective treatment requires more than just access to medication